Spots Global Cancer Trial Database for Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin
Official Title: Uterine Artery Blood Flow in Pregnant Women With Polycystic Ovary Syndrome(PCOS)Treated With Metformin - a Substudy to The PregMet Study
Study ID: NCT00466622
Conditions
Study Description
Brief Summary: FlowMet study is a "sub-study" of the PregMet study (registered in 2005). The aim of the FlowMet study is to register the possible effect of metformin on the blood flow of the uterine artery in pregnant PCOS women. The participants will be examined with ultrasound Doppler in gestational week 10-13: 1. before and 3h after the first tablet intake of metformin/placebo 2. and 10-14 days after inclusion in the trial 3. blood flow in the umbilical artery and fetal cerebral artery in gestational week 24.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Dept. of Obstetrics and Gynecology, National Center for fetal Medicine, University Hospital of Trondheim, Trondheim, , Norway
Contact Details
Name: Eszter Vanky, MD, Phd
Affiliation: Norwegian University of Science and Technology
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
